Pikralida logo

Pikralida

Pikralida - A drug development company

20 employees · est. 2019 · Poznan, Poland

VS
Vectura Group logo

Vectura Group

We are a specialist inhalation CDMO helping you bring innovative inhaled medicines to market.

238 employees · est. 1997 · Chippenham, United Kingdom

Vectura Group is the older company (2019 vs 1997); Vectura Group is the larger of the two.

Side-by-Side Comparison

Pikralida Vectura Group
Founded
2019 1997 older
Headquarters
Poznan, Poland Chippenham, United Kingdom
Employees
20 238 larger
Industry
Not tracked yet Not tracked yet
Funding Stage
Unknown Unknown
Total Funding
$16.70M $1.26B
Funding Rounds
2 6
Services
Contract Research Services, Research and Development Projects, Therapeutic Innovations Inhalation Product Development, Inhalation Formulation Expertise, Bespoke Inhalation Device Design, Inhalation Clinical Trial Production and Supply, Drug and Reagent Handling, Assembly Labeling and Packaging
Target Customers
Pharmaceutical Companies, Biotech Firms, Healthcare Innovators Pharmaceutical Companies, MedTech Companies, Biotech Companies, Healthcare Providers, Patients
Taxonomy
Contract Research Organization, Drug Development, Neuroprotection, Stroke Therapy, Snakebite Treatment, MMP Inhibitors, Pharmaceutical Research, Therapeutic Innovation, Preclinical Programs, Clinical-stage Development, Pharmaceutical Analysis, Formulation Development, Strategic Partnerships, Global Market Introduction Inhalation CDMO, Inhaled Drug Delivery, Pharmaceutical Development, Inhaled Medicines, Proprietary Technology, Asthma Treatment, COPD Treatment, Respiratory Therapies, Airways Diseases, Formulation Development, Drug Development, Royalty Streams, Clinical Development, Life Sciences
Website
pikralida.eu vectura.com
Pikralida logo

About Pikralida

Pikralida, founded in 2019 and headquartered in Poland, is a dynamic biotechnology company that seamlessly integrates the development of innovative therapies with Contract Research Organization (CRO) services. Its hybrid business model offers both proprietary drug development and partnered research...

Vectura Group logo

About Vectura Group

Vectura Group is a UK-based specialist in inhalation drug delivery, leveraging its extensive expertise in developing and delivering complex inhaled therapies. Founded in 1997, Vectura boasts proprietary technology and pharmaceutical development expertise, positioning itself as a unique player in the...

We will tell you when either one moves

BounceWatch watches Pikralida and Vectura Group for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Pikralida and Vectura Group — by email.

Frequently Asked Questions

Pikralida — Pikralida - A drug development company. Vectura Group — We are a specialist inhalation CDMO helping you bring innovative inhaled medicines to market.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Pikralida has raised $16.70M while Vectura Group has raised $1.26B.
Pikralida and Vectura Group operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Pikralida with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Pikralida on 11 Mar 2026, and Vectura Group on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy